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ABSTRACT: Although backbone hydrogen bonds in trans-
membrane (TM) helices have the potential to be very strong
due to the low dielectric and low water environment of the
membrane, their strength has never been assessed exper-
imentally. Moreover, variations in hydrogen bond strength
might be necessary to facilitate the TM helix breaking and
bending that is often needed to satisfy functional imperatives.
Here we employed equilibrium hydrogen/deuterium fractio-
nation factors to measure backbone hydrogen bond strengths
in the TM helix of the amyloid precursor protein (APP). We
find an enormous range of hydrogen bond free energies, with
some weaker than water−water hydrogen bonds and some
over 6 kcal/mol stronger than water−water hydrogen bonds.
We find that weak hydrogen bonds are at or near preferred γ-secretase cleavage sites, suggesting that the sequence of APP and
possibly other cleaved TM helices may be designed, in part, to make their backbones accessible for cleavage. The finding that
hydrogen bond strengths in a TM helix can vary widely has implications for membrane protein function, dynamics, evolution,
and design.
■ INTRODUCTION
The apolar membrane creates an ideal environment for making
strong hydrogen bonds. Nevertheless, direct measurements of
hydrogen bonds made between amino acid side chains in
membrane proteins indicate that their full potential strength is
rarely realized, presumably because side-chain flexibility and
water penetration into membrane proteins afford many
opportunities for competing hydrogen bonds.1−10 However,
backbone hydrogen bonds might be generally stronger than
side-chain hydrogen bonds because there are fewer alternative
hydrogen bonding partners. On the other hand, strong
backbone hydrogen bonds would make it difficult to create
the many transmembrane (TM) helix distortions and
breaks11−13 often required for function.14−18 We previously
argued that one important mechanism for generating TM helix
distortions is through the formation of alternative backbone
hydrogen bonds, i.e., shifts from canonical i+4 α-helical
hydrogen bonds to i+3 or i+5 hydrogen bonds, thereby
maintaining hydrogen bonding, yet allowing for conformational
flexibility.19 It also remains possible that that the sequences
evolved to optimize hydrogen bond strengths, sometimes to
create weak points in TM helices as needed to satisfy functional
requirements.
To test the possibility that backbone hydrogen bond
strengths might be variable we sought a direct way to measure
backbone hydrogen bond free energies. While the strength of
side-chain hydrogen bonds can be probed by site-directed
mutagenesis,1,9,10,20−34 this approach is not possible for
backbone hydrogen bonds. Introducing amide-to-ester back-
bone changes into proteins via chemical synthesis provides an
alternative way to address this issue,35−38 but requires
thermodynamic stability measurements relative to a reference
state where hydrogen bonds are broken, which is difficult to
achieve for TM helices. A non-perturbing method for assessing
hydrogen bond strength is to use equilibrium H/D
fractionation factors (ϕ-values) by measuring the following
equilibrium:
+ ··· ⇌ + ···   1
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The weaker the hydrogen bond, the stronger the preference
for D over H.39−52 The preference for D over H with reference
to that in water is defined by the equilibrium constant or ϕ-
value:
ϕ = ··· ···   [N D O C]/[N H O C]
[D] /[H]w w
where [D]w and [H]w are the concentrations of deuterons and
protons in water.
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We previously placed ϕ-values on an energetic scale by
developing a semiempirical relationship between ϕ and the free
energy required for breaking hydrogen bonds (ΔGHB).39 We
obtained a scale factor (SF), defined as SF = ∂(ΔGHB)/
∂(RT ln ϕ), that relates the two parameters. We determined
this scale factor to be −7.0 ± 0.7.39 Thus, ϕ-value
measurements allow the determination of relative hydrogen
bond strengths.
We decided to focus on the TM helix of the amyloid
precursor protein (APP) where there may be functional reasons
to create weak points in the backbone. The plaques in the
brains of Alzheimer’s disease patients53,54 are formed by the
aggregation of short amyloid-beta (Aβ) peptides that are
generated by sequential proteolysis of the membrane-anchored
APP.55−57 Proteolysis by β-secretase first releases the
ectodomain from the APP, producing the 99-residue C-
terminal domain (C99 or APP672−770), a single-span TM
protein. The structure of monomeric C99 in lyso-myristoyl-
phosphatidylglycerol (LMPC) micelles derived from NMR
constraints58 is schematically represented in Figure 1. The TM
domain is bent at a kink around a diglycine hinge (G37, G38).
Cleavage of C99 occurs processively C-terminal to the diglycine
hinge, usually in three residue steps. The primary cleavage
pathways are Aβ48 → Aβ45 → Aβ42 and Aβ49 → Aβ46 →
Aβ43 → Aβ40, yielding the major final fragments Aβ42 and
Aβ40. As Aβ42 is more toxic than Aβ40, the pattern of cleavage
has important disease implications. While full-length C9959,60
and derived TM domain-containing fragments61−65 form
homodimers under some conditions, it appears that γ-secretase
binds and cleaves only the monomeric form of C99.66−69
A number of mechanisms have been suggested to contribute
to the γ-secretase cleavage of C99, including (1) recognition of
the N-terminal half of the C99 TM helix, preceding the
diglycine hinge;59,70−72 (2) flexibility of the diglycine
hinge72−74 allowing entry of the C-terminal end of the C99
TM helix into the mouth of the γ-secretase active site; (3) an
intrinsic propensity of the helix to break62 since helices need to
unfold at least around their cleavage sites before proteolysis;75
(4) effects of the membrane environment on recognition,
dynamics, and conformation of the helix;72,76−80 (5) conforma-
tional changes in γ-secretase for binding the helix;80−82 and (6)
a three-residue recognition site within γ-secretase for sequential
cleavage of the helix.83
Since hydrogen bonding is one of the main interactions that
stabilize helices2−4,84−88 and backbone hydrogen bonds have to
be broken during helix unwinding, the strength of backbone
hydrogen bonds may be an important determinant of cleavage
site preference. Somewhat counter-intuitively, the C-terminal
half of the TM domain (where cleavage occurs)was found to be
less flexible than the N-terminal domain based on hydrogen/
deuterium (H/D) exchange rate measurements and molecular
dynamics simulations.74 Nevertheless, fraying at the C-terminal
end near the initial cut site was observed, likely favoring the
initial cleavage event, a result substantiated by the finding that
C-terminal extensions inhibited ε-site cleavage.62
NMR spectroscopy has been used to measure ϕ-values of
hydrogen bonds in DNA and water-soluble proteins42−51 by
allowing the H/D exchange reaction to come to equilibrium. In
the case of C99, however, we found that the half-life of H/D
exchange for many amides in the TM helix are in the scale of
weeks or more at 45 °C and would take too long to reach
equilibrium. We therefore adopted an alternative approach to
obtain the ϕ-values by measuring forward and reverse exchange
rate constants. Since ϕ-values are the equilibrium constant of
reaction [1], they can be calculated as ϕ = k(H→D)/k(D→H),
where k(H→D) and k(D→H) are the overall rate constants for
H-to-D exchange and D-to-H exchange, respectively. Using this
method, it is not necessary to wait until equilibrium has been
achieved. Exchange rates in a TM helix will be a complex
function of not only hydrogen bond strength but also flexibility,
water accessibility, and unknown hydroxide concentrations, yet
these factors cancel in the equilibrium ϕ-value calculation. The
approach yields ϕ-values regardless of whether exchange
proceeds by the EX1 or EX2 mechanism as long as all
exchange reactions being compared proceed via the same
mechanism. It can be concluded, however, from the discussion
in Pester et al.73 that hydrogen exchange in the C99 TM helix
proceeds by the EX2 mechanism.
■ MATERIALS AND METHODS
Protein Preparation. To measure amide k(H→D) and k(D→H)
using NMR spectroscopy, we expressed and purified C-terminally
6XHis-tagged C99 following either 15N uniform labeling (U-15N-C99)
or selective 15N-labeling at glycine, leucine, valine, and threonine
(GLVT-15N-C99). The protocol was similar to those used before,1−3
but 15N-labeled glycine, leucine, valine, and threonine and [14N]-
ammonium chloride were used in the culture media as the nitrogen
source for expressing GLVT-15N-C99. After purification, the samples
were concentrated to produce samples containing 9% (w/v) lyso-
myristoylphosphatidylglycerol (LMPG, Anatrace), 25 mM imidazole,
20 mM sodium acetate, 100 mM NaCl, and 1 mM Na2·EDTA (pH
Figure 1. C99 structure and cleavage sites. Upper: Illustration of the
backbone structure of C99 (residues 12−57 only) determined via
solution-state NMR (PDB code: 2LP1). The locations of the ε-, ζ-,
and γ-cut sites are colored in pink, magenta, and cyan, respectively.
Lower: Amino acid sequence of the transmembrane helix of C99
(residues 30−52). The arrows point toward the scissile bonds, using
the same color coding as in the structure cartoon. The diglycine hinge
is underlined in the amino acid sequence in purple. Residues outside
the TM helix are colored in gray. The two primary cleavage products
Aβ40 and Aβ42 are depicted under the sequence.
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6.5). The concentrated samples were first used for collecting the H-to-
D exchange data. The samples were then flash-frozen using liquid
nitrogen and stored at −20 °C until collection of D-to-H exchange
data (see below).
Measurement of Exchange Rate Constants. For the H-to-D
exchange reactions, buffer exchange was accomplished by two rounds
of dilution and concentration at room temperature. In the first round,
a 0.5 mL sample including 0.39 mM U-15N-C99 or 0.25 mM
GLVT-15N-C99 and 5% D2O was mixed with a 9-fold volume of the
D2O dilution buffer at pH 6.5. The D2O dilution buffer included
99.7% (v/v) D2O and matched the components of the original buffer
minus LMPG. The sample was then concentrated to between 0.5 and
1.6 mL using a 10 kDa MWCO centrifugal concentrators (Millipore
Amicon) at 1000g. Next, the sample was diluted 1- to 5-fold with the
D2O dilution buffer, followed by concentration to ∼0.5 mL so that the
protein concentration was the same as the initial value. In the final
buffer-exchanged samples, D2O concentrations were all 96−98% (v/
v).
For the D-to-H exchanges, the buffer exchange was accomplished
after only one round of dilution and concentration at room
temperature. A 0.5 mL sample including 0.39 mM U-15N-C99 or
0.25 mM GLVT-15N-C99 and 96−98% (v/v) D2O recycled from the
H-to-D exchange experiments was thawed in a water bath at room
temperature and mixed with a 9-fold volume of the H2O dilution
buffer at pH 6.5. The H2O dilution buffer included H2O and matched
the components of the original buffer minus LMPG. The sample was
then concentrated to ∼0.5 mL, leaving the protein concentration the
same as its initial value. In the final buffer-exchanged samples, D2O
concentrations were all 10% (v/v).
During the buffer exchange reactions for both the H-to-D and D-to-
H exchange, the protein concentration was determined by measuring
the protein concentration by absorbance at 280 nm, using a Nanodrop
UV−vis absorbance spectrometer. No LMPG was found in the flow-
through by 1-dimensional 13C NMR. Since the LMPG-to-protein
molar ratio did not change during the buffer exchanges, the LMPG
concentration was also the same as its initial value.
Soon after buffer exchange, samples were transferred into NMR
tubes with a sealed capillary placed in the center, coaxially aligned with
the NMR tubes. The sealed capillary contained 1 mM 15N-labled N-
acetylglycine solution in H2O and served as an “external” reference to
normalize cross peak intensities. The NMR tubes were then placed in
an 800 MHz NMR spectrometer pre-equilibrated at 45 °C. The buffer
exchanges, sample transfer, and NMR tube placement were
accomplished within 2 h.
After 20−30 min, 1H,15N-TROSY HSQC89−91 (for U-15N-C99 at
0.39 mM) or SOFAST HMQC92,93 (for GLVT-15N-C99 at 0.25 mM)
NMR spectra were recorded continuously in the beginning so as to be
able to monitor fast-exchanging residues and then once every several
days to monitor slow-exchanging residues. Although the cross peaks
for most residues in the TM helix of C99 could be located in the
TROSY HSQC spectra, those for some glycine, leucine, valine, and
threonine residues in C99 were partially overlapped with signals from
imidazole or other residues. For the TM domain specifically, TROSY
HSQC spectra on U-15N-C99 were used for monitoring the amides of
M35, A42, I45, I47, and M51 only. To fully resolve the cross peaks for
the remaining glycine, leucine, valine, and threonine residues, we
employed GLVT-15N-C99 and the SOFAST HMQC pulse program.
All samples were kept at 45 °C after the first spectrum was
recorded. Each acquisition took 1 h with 16 scans each per 200
increments for TROSY HSQC and 0.5 h with 48 scans each per 100
increments for SOFAST HMQC. Changes in cross peak intensities
were monitored to measure the rate constants. Cross peak intensities
of exchangeable amides in the TM helix of C99 for all time points were
normalized relative to the external standard (15N-labeled N-
acetylglycine). For each residue, a further normalization of its cross
peak intensities was made using the first data point for the H-to-D
exchange and the last data point for the D-to-H exchange. The
normalized cross peak intensities at two nearby time points were then
averaged, i.e., y1 = (I1 + I2)/2, y2 = (I3 + I4)/2, y3 = (I5 + I6)/2, etc., for
all residues but the fastest-exchanging residues, L34, M35, and G38,
and the slowest-exchanging residues, V44 and T48. Since the half-lives
of the amide H-to-D and D-to-H exchange processes for L34, M35,
and G38 were on the order of magnitude of only ∼1 h, we did not
average their peak intensities at nearby time points to avoid affecting
the time resolution of their exchanges. Since the half-lives of the amide
H-to-D and D-to-H exchanges for T44 and T48 were more than 800
h, their normalized cross peak intensities at time points collected
within ∼10 h were averaged. For D-to-H exchange, the cross peak
intensities for fast-exchanging residues L34, M35, and G38 reached
their plateaus within 1 day. After that, although no D-to-H exchange
took place for these residues, their cross peak intensities fluctuated
within the range of experimental errors in time until the all data
collection was completed ∼1 month later. Therefore, if t0 are the time
points at which they reached their plateaus, we truncated their D-to-H
exchange plots at 2t0 when we fit the plots to derive their k(D→H)
values. The purpose of data averaging and D-to-H exchange plot
truncations was to reduce the fitting error while keeping the change of
cross peak intensities during exchanges unaffected. Of the 23 residues
in the TM helix of C99, residues 30−33 at the N-terminal region
underwent H/D exchange that was too fast for us to measure. At the
other extreme, we could observe no H/D exchange for residues I45,
V46, or I47 over the course of several weeks. The cross peak for I41
was highly overlapped with that for V50 in the TROSY HSQC spectra
for U-15N-C99 and did not show up in the SOFAST HMQC spectra
for GLVT-15N-C99. Therefore, we could not obtain the H/D
exchange rate constants for this residue, either. For the remaining
15 residues, we could observe H/D exchange in both directions or at
least in the H-to-D exchange direction. Their measurable rate
constants were obtained by fitting the plots of the normalized and
averaged cross peak intensities against time. For H-to-D exchanges, the
equation for fitting was
= − → *y a k texp{ (H D) }
where t is time, a is a constant, and k(H→D)* is the apparent rate
constant and equals the product of k(H→D) and the concentration of
deuterons in water ([D]w). For D-to-H exchange, the equation for
fitting was
= − − → * +y b k t cexp{ (D H) }
where b is a constant, c = y at t = +∞, and k(D→H)* is the apparent
rate constant and equals the product of k(D→H) and the
concentration of protons in water ([H]w). [D]w for the H-to-D
exchanges and [H]w for the D-to-H exchanges were 96−98% and 90%
of the concentration of water hydrogens (110 M), respectively. The H-
to-D and D-to-H exchange experiments were accomplished within
about 2 and 4 weeks, respectively. For each residue, the ϕ-value was
calculated as ϕ = k(H→D)/k(D→H), and the averaged ϕ-value from
the duplicates is reported here. The uncertainty of each ϕ-value is half
the difference between the ϕ-values from the duplicates.
Analysis of Backbone Hydrogen Bond Geometry. The
ensemble of solution state NMR structures in PDB 2LP1 for C99 in
LMPG micelles was used for this analysis. It should be clarified that,
while the original experimental studies leading to this ensemble
employed full-length C99, both the N-terminus and C-terminus of
C99 were seen to be largely disordered, such that coordinates were
reported in the PDB file only for the relatively well ordered
transmembrane and juxtamembrane segments encompassed by
residues 12−57 in C99 numbering, corresponding to residues 683−
728 in full-length amyloid precursor protein numbering. The geometry
of backbone hydrogen bonds in each model of the solution-state NMR
structure of C99 was analyzed from coordinates of the relevant atoms.
The distance between any two arbitrary atoms A and B (dAB) was
calculated as
= − + − + −d x x y y z z[( ) ( ) ( ) ]AB A B 2 A B
2
A B
2 1/2
where (xA, yA, zA) and (xB, yB, zB) are the coordinates of atoms A and
B, respectively. The angle formed by any two arbitrary adjacent bonds
A−B and B−C (θABC) was calculated as
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θ π= + −d d d d d(180 / ) arccos[( )/(2 )]ABC o AB2 BC2 AC2 AB BC
where the multiplier 180°/π was used to convert the unit of angles
from radians to degrees.
Since the amide NH group of each residue in the TM helix of C99
can potentially form either i,i+3 or i,i+4 backbone hydrogen bonds
with the carbonyl groups of their preceding residues,94 we determined
which type of hydrogen bond the NH group was more highly
populated in, and used that for the geometry calculations. To
determine the major type of backbone hydrogen bond, we first
calculated the backbone N−O distances (dNO)and the NHO angles
(θNHO) for each residue in every model for both i,i+3 and i,i+4
hydrogen bonds. If θNHO is smaller than 100° and/or dNO is larger than
3.5 Å for any type of hydrogen bonds, that type of hydrogen bond was
considered not formed. If one type of hydrogen bond was not formed,
the other type was considered to be the major type of hydrogen bond
if it was formed, and otherwise no hydrogen bond was formed. We
also used these criteria to check the possibility of the formation of i,i+5
backbone hydrogen bonds, but found none. Next, if both i,i+3 and i,i
+4 backbone hydrogen bonds were considered formed by the amide
NH group of a residue in a model, we calculated dHO sin[(180° −
θNHO)(π/180°)] as illustrated in Scheme 1, where dHO is the H−O
distance, and the multiplier π/180° was used to convert the unit of
angles from degrees to radians, for both the i,i+3 and i,i+4 distances.
This product represents the deviation of the carbonyl oxygen from the
extension of the N−H bond. Smaller deviation means larger overlap
between the orbitals of H and O, and vice versa. Therefore, for any
residue in any model, the type of backbone hydrogen bond that has
the smaller deviation of the carbonyl oxygen from the extension of the
N−H bond was considered to be the major type of backbone
hydrogen bond.
■ RESULTS AND DISCUSSION
To obtain well-resolved peaks for all the amide protons, we
employed both uniformly 15N-labeled C99 (U-15N-C99) and
C99 in which only G, L, V, and T residues were labeled with
15N (GLVT-15N-C99). Spectra were recorded in lyso-
myristoylphosphatidylglycerol (LMPG) micelles at a LMPG-
to-C99 molar ratio of more than 500/1. Indeed, no more than
one 1H−15N cross peak was found for the backbone NH group
of each residue in the 1H,15N-TROSY HSQC89−91 and the
SOFAST HMQC92,93 spectra, and each cross peak appeared in
the same positions as found previously.72,73 These observations
indicate that under the conditions of this work C99 still exists
as a single, monomeric state.
To measure the amide H-to-D and D-to-H exchange rate
constants, purified and concentrated U-15N-C99 or GLVT-15N-
C99 samples were buffer-exchanged from H2O (95% (v/v)) to
D2O (96−98% (v/v)) then from D2O (96−98% (v/v)) to H2O
(90% (v/v)). 1H,15N-TROSY HSQC or SOFAST HMQC
spectra were then serially recorded. Because of problems with
peak overlap, we collected and analyzed data both for uniformly
15N-labeled C99 and for C99 that was only GLVT-15N-labeled.
For the H-to-D and D-to-H exchange reactions, we monitored
the disappearance or recovery of amide 1H−15N cross peaks for
the TM helix of C99 relative to the cross peak for the standard
15N-labeled N-acetylglycine over time. This standard was
physically isolated from the protein samples using an NMR
tube insert (see Materials and Methods). The k(H→D) values
for the exchangeable residues were found to vary over 3 orders
of magnitude (Figure 2, Table S1, and Figure S1A−C),
corresponding to half-lives ranging from a few hours to several
weeks. These results are comparable to prior rough measure-
ments of the H-to-D exchange rate constants for amides in this
helix.73 However, in those measurements k(H→D) for each
amide was determined from the cross peak intensities at only
two time points.
Of the 23 residues in the TM helix of C99, we were able to
obtain ϕ-values for 15 amide protons. Among these 15 sites,
amide protons at residues 34−40, 42, 43, and 49−52 were
found to be completely exchangeable, with measurable rate
constants in both the H-to-D and D-to-H exchange directions
(Figure 2, Table S1, and Figure S1A−C,E−G)). For two
residues, V44 and T48, we could only obtain a lower limit for
Scheme 1. Calculation Used To Determine the Major Types
of Backbone Hydrogen Bonds if the Amide NH Group of a
Residue Forms Both i,i+3 and i,i+4 Backbone Hydrogen
Bonds
Figure 2. Amide H/D exchange rate constants for the transmembrane
segment of C99. Upper: Amide H-to-D exchange rates constant.
Lower: Amide D-to-H exchange rate constants. The exchange rate
constants in the logarithm are in units of M−1·hr−1. Error bars
represent the discrepancy between two replicates. Only two error bars
are obvious in each plot, because the error bars for other data points
are smaller than the size of the data points. Positions without data
points are sites where exchange was too slow to measure (residues
45−47 for the H-to-D exchange and residues 44−48 for the D-to-H
exchange) or could not be measured for technical reasons (residue
41).
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the ϕ-values. For the V44 and T48 amides, we obtained the
k(H→D) values by fitting their slow H-to-D exchange time
traces, but we could not measure the k(D→H) values from
their D-to-H exchange time traces because the back exchange
reactions were too slow (Figure 2, Table S1, and Figure
S1C,H)). Nevertheless, we can conclude that the ϕ-values for
V44 and T48 are clearly greater than 1, indicating that these
hydrogen bonds are very weak. For the remaining eight
residues, the H-to-D and D-to-H exchange rate constants were
either too fast or too slow to measure (Figure S1D,H) or could
not be measured accurately due to spectral overlaps (see
Materials and Methods). From our previously determined scale
factor, SF = ∂(ΔGHB)/∂(RT ln ϕ) = −7.0 ± 0.7, we could
convert the measured ϕ-values into ΔGHB (relative to the
water-to-water hydrogen bond). The final ϕ and ΔGHB values
for the 15 measurable hydrogen bonds are summarized in
Figure 3 and Table S1.
We observed a wide variation in hydrogen bond strengths.
Most of the hydrogen bonds in the C99 TM helix are much
stronger than water−water hydrogen bonds, some by more
than 6 kcal/mol, indicating that backbone hydrogen bonds can
be extremely strong. Remarkably, however, some hydrogen
bondsat residues T43, V44, and T48are even weaker than
water−water hydrogen bonds. Counterintuitively, the weakest
hydrogen bonds are found at positions where exchange rates
are slow, suggesting that their environments (e.g. water
accessibility, local pH) are simply unfavorable for exchange.
These results reveal that backbone hydrogen bond strengths in
a TM helix can be far from uniform.
Given the large variation in hydrogen bond strengths we
wondered whether there was any influence on hydrogen bond
geometry in the helix. We therefore examined the N−O
distances for the backbone hydrogen bonds by analyzing the 30
models of the backbone structure of C99 consistent with
solution-state NMR constraints (PDB code: 2LP1). Figure 4
shows the averaged N−O distances (dNO) for backbone
hydrogen bonds that form in 10 or more models against the
residue number each amide NH group. The average of dNO was
taken from all the 30 models. Figure S2 shows the distances for
each individual model.
For residues immediately after the diglycine hinge,72
backbone hydrogen bonds to the NH group of V39, V40,
and I41 were observed in less than 10 models, and their average
dNO values from the 30 models are above 3.5 Å. The existence
of the helix kink centering the diglycine hinge near residues
39−41 makes it impossible for them to find a hydrogen-bond
acceptor in the backbone of the same helix (see Figure 1).
Surprisingly, however, the ϕ-values for V39 and V40 are low,
indicating that these two residues make strong hydrogen bonds.
It seems possible that unseen water molecules manage to insert
at these positions to satisfy the hydrogen bonding potential.
Perhaps the glycine residues are particularly favorable places for
water to penetrate. Indeed, the plots of exchange rates against
residue numbers in Figure 2 show a local maximum around the
G37G38 diglycine hinge, which suggests that this region has a
higher water accessibility than nearby residues. We also note
that the N-terminal region shows high exchange rates,
indicative of water penetration and flexibility and also low ϕ-
values. The low ϕ-values may result from hydrogen bonds not
Figure 3. Hydrogen bond strengths in the transmembrane segment of
C99. ϕ-values are shown in the upper plot, and the corresponding
ΔGHB values are shown in the lower plot for hydrogen bonds formed
by the amide NH groups in the TM helix of C99. The arrows indicate
that the ϕ-values and ΔGHB for both residues 44 and 48 are above 1
and below 0 kcal/mol, respectively. Error bars represent the
discrepancy of the results in two replicates.
Figure 4. Average N−O distance of the backbone hydrogen bonds in
the transmembrane segment of C99. The value in the vertical axis is
the N−O distance averaged from the 30 models of the solution-state
NMR structure of C99 (PDB code: 2LP1). Rectangular boxes are
drawn to indicate the local maxima found at residues 43, 44, and 48.
Results for residues 39−41 are not included in this plot, because their
amide NH groups form backbone hydrogen bonds in less than 10 out
of the 30 models and their averaged dNO values from the 30 models are
also all above 3.5 Å, which is beyond our threshold for hydrogen bond
formation.
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only within the backbone but also between backbone N−H
moieties and water or detergent head groups.
Although the remaining residues in the TM helix of C99
form hydrogen bonds as expected, the averaged dNO values have
local maxima at T43, V44, and T48. This indicates that the
NMR constraints are remarkably consistent with weak amide
hydrogen bonding at T43, V44, and T48 allowing them to
stretch more readily than other residues in the TM helix.
The T48 amide NH group is one residue upstream of the
ε48 cut site (one of the initial γ-secretase cut sites), and the
T43 and V44 amide NH groups are exactly at the γ42 and γ43
cut sites (two of the final γ-secretase cut sites). We were unable
to experimentally determine strengths of the hydrogen bonds in
between these sites. Our findings of the low ϕ and high dNO
values for the NH groups of T43, V44, and T48 suggest that
their backbone hydrogen bonds are weak. Since a helix-to-coil
transition is required for the cleavage of the TM helix in C99 by
γ-secretase,62 it suggests that the local weak points created at
T43, V44, and T48 may enhance the preference of helix-to-coil
transitions near or at these residues and may facilitate the
selection of cut sites by γ-secretase. Indeed, it was previously
observed that this helix adopts a mixture of helical and non-
helical conformations at T43 (as also reported for the kink and
termini) in vesicles using a neuronal lipid mixture at 37 °C.76
Our results not only agree with the finding of flexibility at this
residue but also provide a physical explanation for it.
■ CONCLUSION
To our knowledge, our results provide the first measurements
of backbone hydrogen bond strengths in transmembrane
helices. Most of the hydrogen bonds are much stronger than
water−water hydrogen bonds by at least 3 kcal/mol (Figure 3)
as might be expected for hydrogen bonds in an apolar
environment.22,95,96 Moreover, our measurements are made in
detergent micelles, where water accessibility and helix dynamics
are likely to be even higher than in true bilayers. These results
contrast greatly with experimental measurements of side-chain
hydrogen bonds in membrane proteins, which have generally
be found to be rather weak.1−10 Side chains have considerable
flexibility, however, and can form many alternative, competitive
hydrogen bonds with other polar groups or water.1 In the case
of backbone hydrogen bonds, however, choices for alternative
hydrogen bonds are generally limited, particularly in an isolated
TM helix like in C99. Moreover, there are cooperative avidity
effects due to neighboring hydrogen bonds in a TM helix that
would strengthen individual hydrogen bonds in the helix.
Strong hydrogen bonds might create rigid helices, yet TM
helices must bend and flex during functional cycles. We had
previously proposed a generic mechanism for allowing TM
helix flexibility by shifting backbone hydrogen bond partners.19
Here we suggest additional more specific mechanisms for
allowing flexibility that may also operate. In particular, we
suggest that the kinked conformation of the diglycine hinge is
stabilized by hydrogen bonding to cryptic water molecules. It is
known that the TM helix of C99 can shift between the kinked
and straight conformations when it is solubilized in different
lipid environments.97 The penetration of water molecules at the
diglycine hinge provides a mechanism for allowing kinking
without the loss of hydrogen bonds.17 Our results also suggest
that the TM helix sequence can encode weaker backbone
hydrogen bonds at specific locations, generating possible
locations for more facile helix distortions. The fact that it is
possible to encode hydrogen bond strength variation in a TM
helix suggest that hydrogen bond strength variation could be
utilized by evolution to provide functional information, i.e., sites
that facilitate membrane protein dynamics or in the case of
C99, perhaps cleavage site preferences. How sequences can
encode hydrogen bond strength variations in TM helices is an
interesting potential area of investigation. In this regard, it is
noteworthy that T43 and T48, where weak backbone amide
hydrogen bonds occur, are the only two hydrophilic residues in
the TM helix.
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